In the combined cohort, the prevalence of SULF2, JPH3, PCDH20, and p16 methylation were all significantly higher in males with CMH compared to males without CMH (p < 0.05, all analyses). This evidence concerns the gene SULF2 and hypertrophic cardiomyopathy 1.